MYRIAD WOMEN'S HEALTH, INC. Patent Application Trends in 2025
Appearance
MYRIAD WOMEN'S HEALTH, INC. Patent Filing Activity
MYRIAD WOMEN'S HEALTH, INC. patent applications in 2025
Top 10 Technology Areas
- C12Q1/6886 (for cancer (immunoassay for cancer)
- Count: 2 patents
- Example: 20250034647. LABORATORY EXECUTION AND AUTOMATION SYSTEMS (Myriad Women's Health, Inc.)
- C12Q2600/156 (MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS (immunoassay)
- Count: 2 patents
- Example: 20250034647. LABORATORY EXECUTION AND AUTOMATION SYSTEMS (Myriad Women's Health, Inc.)
- G01N35/0099 (Automatic analysis not limited to methods or materials provided for in any single one of groups)
- Count: 1 patents
- Example: 20250034647. LABORATORY EXECUTION AND AUTOMATION SYSTEMS (Myriad Women's Health, Inc.)
- C12Q1/6818 (involving interaction of two or more labels, e.g. resonant energy transfer)
- Count: 1 patents
- Example: 20250066862. LABORATORY EXECUTION AND AUTOMATION SYSTEMS (Myriad Women's Health, Inc.)
- C12Q1/6874 (involving nucleic acid arrays, e.g. sequencing by hybridisation)
- Count: 1 patents
- Example: 20250066862. LABORATORY EXECUTION AND AUTOMATION SYSTEMS (Myriad Women's Health, Inc.)
- G06Q10/0635 (Risk analysis of enterprise or organisation activities)
- G16H10/20 (for electronic clinical trials or questionnaires)
- G16H10/60 (for patient-specific data, e.g. for electronic patient records)
Emerging Technology Areas
Error creating thumbnail: File missing
- G16H10/60 (for patient-specific data, e.g. for electronic patient records)
- G16H10/20 (for electronic clinical trials or questionnaires)
- G06Q10/0635 (Risk analysis of enterprise or organisation activities)
- C12Q1/6874 (involving nucleic acid arrays, e.g. sequencing by hybridisation)
- Count: 1 patents
- Example: 20250066862. LABORATORY EXECUTION AND AUTOMATION SYSTEMS (Myriad Women's Health, Inc.)
- C12Q1/6818 (involving interaction of two or more labels, e.g. resonant energy transfer)
- Count: 1 patents
- Example: 20250066862. LABORATORY EXECUTION AND AUTOMATION SYSTEMS (Myriad Women's Health, Inc.)
- G01N35/0099 (Automatic analysis not limited to methods or materials provided for in any single one of groups)
- Count: 1 patents
- Example: 20250034647. LABORATORY EXECUTION AND AUTOMATION SYSTEMS (Myriad Women's Health, Inc.)
- C12Q2600/156 (MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS (immunoassay)
- Count: 2 patents
- Example: 20250034647. LABORATORY EXECUTION AND AUTOMATION SYSTEMS (Myriad Women's Health, Inc.)
- C12Q1/6886 (for cancer (immunoassay for cancer)
- Count: 2 patents
- Example: 20250034647. LABORATORY EXECUTION AND AUTOMATION SYSTEMS (Myriad Women's Health, Inc.)
Top Inventors
- Jared Robert Maguire of San Francisco CA (US) (2 patents)
- Clement S. Chu of San Francisco CA (US) (2 patents)
- Imran Saeedul Haque of San Francisco CA (US) (2 patents)
- Eric Andrew Evans of San Bruno CA (US) (2 patents)
- Noah Welker of Half Moon Bay CA (US) (2 patents)
- Jonathan E. Brown of Sausalito CA (US) (1 patent)
- Matthew Joseph Maher of Rescue CA (US) (1 patent)